CORTEXA
← Browse
openalexFrontiers in Oncology2026-07-24Cited by 0

Down-regulation of THBS2 inhibits the malignant progression of Burkitt lymphoma by blocking the PI3K/AKT/c-MYC pathway

Yan Xu, Shengquan Liu, Shaoxiong Wang, Y Huang

Background Thrombospondin 2 (THBS2) is overexpressed in various solid tumors and is a prognostic gene of Burkitt lymphoma (BL), but its role and molecular mechanism in BL still need to be explored. Methods Western blot (WB) detected the protein expression of THBS2 in BL cells. si-THBS2 was transfected into CA46 and RAJI cells to detect cell malignant phenotype and cell cycle changes. WB detected the protein expression of epithelial-mesenchymal transition (EMT), apoptosis, cell cycle and the PI3K/AKT/c-MYC pathway proteins. ChIP-qPCR detected the binding ability of MYC to target gene promoters, and Co-IP detected the level of MYC/MAX dimerization. Tumor stem cell sphere formation assays evaluated cell stemness changes. The subcutaneous xenograft model of RAJI cells was developed to observe the effect of THBS2 knockdown on tumor growth. Results THBS2 protein was markedly up-regulated in BL cells. Knockdown of THBS2 could inhibit the growth and EMT process, inhibit the protein levels of cyclins (CDK2, CDK4, CDK6 and CyclinD1), inhibit the sphere formation ability of stem cells and down-regulate SOX2 and OCT4 expressions. THBS2 knockdown inhibited the PI3K/AKT pathway phosphorylation, declined c-MYC expressions, weakened the MYC/MAX dimerization and the binding ability of MYC to target gene promoters. In addition, THBS2 knockdown also significantly inhibited the growth of subcutaneous xenografts of RAJI cells, reduced the positive rates of Ki67 and PCNA, declined the protein levels of cyclins, and inhibited the PI3K/AKT/c-MYC pathway. Overexpression of c-MYC or 740Y-P treatment partially reversed the tumor malignant phenotype inhibition caused by THBS2 knockdown and partially restored cyclin levels. Conclusion Knockdown of THBS2 inhibited the malignant phenotype, EMT and stem cell-like characteristics via inhibiting the PI3K/AKT/c-MYC signaling axis, and blocked the cell cycle.

View free PDFSource page

Related papers

openalexFrontiers in Oncology2026-07-24

Case Report: Long-term survival in extensive-stage small cell lung cancer treated with adebrelimab-based combination therapy

Xia Y, Yuxian Yang, Wanzhong Huang, Yongshun Chen

The integration of immune checkpoint inhibitors into first-line treatment has markedly improved outcomes for extensive-stage small cell lung cancer (ES-SCLC). Adebrelimab, a PD-L1 inhibitor, demonstrated superior overall survival in the phase 3 CAPSTONE-1 trial. We present a deta…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells

R K Watanabe, Mami Chosei, Haruna Arai, Noriyoshi Miura, Tadahiko Kikugawa, Takashi Saika

Introduction Neuroendocrine prostate cancer (NEPC) is an aggressive treatment-associated lineage state emerging with potent androgen receptor (AR) pathway inhibition. Although treatment-emergent NEPC is increasingly recognized, the transcriptional consequences of sustained AR sup…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Construction and validation of a machine learning model for predicting anastomotic leak following radical esophagectomy for esophageal cancer

Yueying Yang, Kayishaer Ainiwaer, Yunfei Gao, An Li, Abulajiang Kamili, Dongbo Luo

Background Early identification of patients at high risk of anastomotic leak (AL) following esophagectomy is essential for improving surgical outcomes. However, reliable preoperative risk stratification remains challenging. This study aimed to predict AL risk in the esophageal ca…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Spontaneous rupture of a clinically recurrent intracranial dermoid cyst: a case report and narrative review

Hongyuan Liu, Hui Zeng, Bufan Yang, Yuzhu Ji, Zongping Li, Liangxue Zhou

Objective To describe the clinical, pathological, and therapeutic features of spontaneous rupture of a recurrent intracranial dermoid cyst (IDC), and to summarize relevant dermoid-specific literature. Methods We report a 38-year-old woman with a clinical history of resection of a…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth

Gaochao Guo, Yan Sun, Rujun Hong, Yalin Lu, Xingjie Chen, Liming Zhao, et al.

Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE), a member of the serine/threonine kinase family, is an important oncogene in glioblastoma. IKBKE is involved in the progression of multiple tumours in glioblastoma (GBM), including tumour invasion, migration, and…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Overcoming immunotherapy barriers in pediatric brain tumors: epigenetic strategies

Ashley R Tetens, Jordyn Craig-Schwartz, Tyler Findlay, Michael A. Koldobskiy

The advent of cancer immunotherapy has led to dramatically improved outcomes in several immunogenic adult cancers. Similar successes have been seen in some pediatric cancers, but only in specific settings. A particular challenge has been the application of immunotherapy approache…

View free PDFSource page